The global autoinjectors market seems to be a very lucrative, attractive, and profitable market, both for existing as well as new entrants. At the same time, intense rivalry among existing competitors has been observed. Our analysis revealed that market players had adopted different strategies to increase their business and position in the global autoinjectors market. In recent years, strategic movements by major players were product launches, mergers and acquisitions, licensing agreement, collaboration/partnerships, establishment of subsidiary, and expansions, which have been used as market penetration strategies and to reduce competition. The major players in the global autoinjectors market are Amgen Inc., Becton, Dickinson and Company, Abbvie Inc., Mylan N.V., Eli Lilly and Company, Ypsomed, Owen Mumford Ltd, Consort Medical, SHL Group, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd, Antares Pharma, and others.
There are numerous players operating in this market all over the globe. Most of these players exist in the American and European regions. There are a lot of large and small market players available in the market which provide a wide range of products for various applications. As there are many large and small players in the market, the market shares of these players are much differentiated. SHL Group, Mylan N.V., Abbvie Inc., Amgen Inc., and Eli Lilly and Company, are top players in the global autoinjectors market. Other prominent players are Becton, Dickinson and Company, Ypsomed, Antares Pharma, Inc., Consort Medical, Johnson & Johnson Services Inc.
Bargaining Power of Suppliers
Bargaining power of suppliers in the global autoinjectors market is medium. The suppliers in the global autoinjectors industry are medical device manufacturers. Currently, a moderate number of suppliers are present in the market due to stringent government regulations and high opportunities. Major players are accounting for a significant share of the market. Switching cost of the suppliers is medium because suppliers tend to enter into long-term associations, partnership, and deals with the companies that sell autoinjectors.
Bargaining Power of Buyers
The bargaining power of the buyers is medium in the global autoinjectors market due to the presence of many buyers of autoinjectors. The buyers of autoinjectors are moderately inclined towards product manufacturers. Moreover, the buyers can exert moderate pressure on the manufacturers as they already provide high-quality products and services. The market is captured by a limited number of players which indicates oligopoly in the market which leads to fewer options with regards to product offering thus the bargaining power of buyers tends to be medium in this market.
Threat of New Entrants
The threat of new entrants is low to medium in the global autoinjectors market. Any company trying to enter the autoinjectors market is required to accept the regulatory standards and product should get approval by regulatory authorities. This market is also characterized by a reasonable degree of brand loyalty where establishing a brand name is difficult for new entrants. Moreover, products which are already available in the market are patented, and the cost involved in R&D is high which creates unfavorable conditions for the new entrants in the market.
Threat of Substitutes
The threat of substitutes in the global autoinjectors market is medium to high. Substitutes pose a moderate to high threat in the global autoinjectors market due to the availability of similar products which are offered by major market players. However, the excellent product quality and brand loyalty of customers when it comes to emergency care products such as EpiPen (epinephrine autoinjectors) may restrict the threat by the substitutes to an extent. Also, the low-medium degree of switching cost may minimize the threat of substitutes.
Intensity of Rivalry
The degree of competition in the global autoinjectors market is high. Many manufacturers are present in the market. The market is shared by many major players, and their market share is fixed which indicates the high rivalry. Players are engaged in developing a process to lower their manufacturing cost to overcome the competition. Moreover, the players are also developing advanced techniques to differentiate their product from their rivals.
